FDA on Adverse Events With ReShape, Orbera Intragastric Balloons FDA on Adverse Events With ReShape, Orbera Intragastric Balloons

US agency is warning of previously unrecognized adverse events -- overinflation and acute pancreatitis -- that can occur within days of placement of these two types of fluid-filled intragastric balloons.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news